Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

INTRODUCTION: We used the data of the German biologics register RABBIT, a nationwide prospective cohort study, to investigate the risk of new or recurrent malignancy in patients with rheumatoid arthritis (RA) receiving biologics compared to conventional disease modifying anti-rheumatic drugs (DMARDs...

Descripción completa

Detalles Bibliográficos
Autores principales: Strangfeld, Anja, Hierse, Franka, Rau, Rolf, Burmester, Gerd-Ruediger, Krummel-Lorenz, Brigitte, Demary, Winfried, Listing, Joachim, Zink, Angela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875631/
https://www.ncbi.nlm.nih.gov/pubmed/20064207
http://dx.doi.org/10.1186/ar2904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875631/
https://www.ncbi.nlm.nih.gov/pubmed/20064207
http://dx.doi.org/10.1186/ar2904

Ejemplares similares